Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in UROGEN PHARMA LTD
BNP PARIBAS FINANCIAL MARKETS holds 9,246 shares of URGN (UROGEN PHARMA LTD), worth $216,541 as of 2025-Q4. The position was decreased (-97.0% shares). URGN represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$216,541
Current Shares
9,246
Total Value Change
+$171,973
Total Shares Change
+6,590
Other major holders of URGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 9,246 |
-97.0% |
| $216,541 |
| 0.0% |
| $23.17 |
0 |
| 2025-Q3 | Increased | 308,328 | +328.7% | $6.2M | 0.0% | $19.14 | 44 |
| 2025-Q2 | Increased | 71,921 | +2874.4% | $985,318 | 0.0% | $13.49 | 40 |
| 2025-Q1 | Decreased | 2,418 | -49.6% | $26,743 | 0.0% | $11.20 | 0 |
| 2024-Q4 | Decreased | 4,801 | -43.8% | $51,131 | 0.0% | $10.52 | 0 |
| 2024-Q3 | Increased | 8,546 | +221.8% | $108,534 | 0.0% | $12.90 | 35 |
| 2024-Q2 | Decreased | 2,656 | -93.3% | $44,568 | 0.0% | $16.78 | 0 |